Clinical Trial Update: Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update describing a donor stem cell transplant conditioning regimen with treosulfan, fludarabine, and total-body irradiation for various …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Burkitt Lymphoma
• Chronic Myeloid Leukemia
• Diffuse Large B-cell Lymphoma
• Hodgkin Lymphoma
• Mantle Cell Lymphoma
• Myelodysplastic Syndrome

Drugs mentioned

• Fludarabine (Fludarabine)
• Treosulfan (treosulfan)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Acute Leukemia, Acute Lymphoblastic Leukemia | Phase 2 | Status: RECRUITING